NECLIFENSENectar Lifesciences Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 16 Jun · 11:43 IST

Notice of IEPF transfer of unclaimed shares and FY19 dividend

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹11.83
prior close
₹11.86
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0-1.1+1.4-1.1-4.5+0.6-2.1-3.0-5.7-7.0
Up moveDown movePending
AI summary

Nectar Lifesciences has published a notice regarding transfer of equity shares with unpaid or unclaimed dividends for 7 consecutive years to the IEPF Authority, and transfer of unclaimed dividend for FY 2018-19 to IEPF. The notice was published in Business Standard (English) and Desh Sewak (Punjabi) on June 16, 2026. The filing is a routine compliance requirement under Section 124(6) of the Companies Act, 2013.

Likely market impact

Shareholders with unclaimed dividends for 7+ years risk losing their shares to IEPF. They should claim dividends before the transfer deadline.